We compared the staging ability and early complications of standard and extended pelvic lymph node dissection (sPLND and ePLND, respectively) in patients with localized bladder cancer during radical cystectomy.
INTRODUCTION
More than 70,000 patients are newly diagnosed with urothelial cancer of the bladder and more than 14,000 patients die of the condition per year in the United States. 1 About 40%
of the patients were found to have muscle invasive bladder cancer (MIBC), with a 25%, lymph node metastasis rate. 2 To date, radical cystectomy with pelvic lymph node dissection (PLND) has been the standard treatment in patients with MIBC if there is no evidence of distant metastasis. 3 Lymph node dissections during radical cystectomy have been regarded as important for both disease staging and therapeutic benefits.
The main discussion regarding PLND in the context of radical cystectomy is the optimal extent of PLND. 4 Evidence shows that higher number of collected lymph nodes is associated with superior survival outcomes. 5, 6 However, there is no consensus regarding the optimal extent of PLND in patients with clinically organ-confined MIBC. 7 Several previous studies had evaluated this conundrum, but they were mostly retrospectively designed, with only a small number of patients, and were mostly evidence level 3 or 4 studies. [8] [9] [10] [11] Neither the European Association of Urology nor the American Urological Association provides clear guidelines regarding the optimal anatomic extent of PLND in dealing with these localized MIBC patients. 12 More importantly, the postoperative complications after standard and extended PLND (sPLND and ePLND, respectively) were poorly investigated to date.
We compared the staging accuracy between ePLND and sPLND in patients with localized MIBC treated during radical cystectomy with PLND in our institution. We also evaluated early (≤30 days) postoperative complications according to PLND extent after surgery. The specimens from PLND were categorized into 5 groups according to the resected anatomic region: (1) external iliac, (2) obturator (including the internal iliac region), (3) common iliac, (4) presacral, and (5) 
MATERIALS AND METHODS

RESULTS
The preoperative clinical and pathologic characteristics of all patients are described in Table 1 . When we compared the perioperative characteristics according to the PLND method, there were no significant differences between the groups, but the patients who underwent sPLND showed significantly worse clinical stage before surgery (p=0.015). The pathologic outcomes including pathologic stages, lymphovascular invasion, surgical margin status and operation time were not significantly different between the 2 groups, but the sPLND group showed a significantly higher grade than the ePLND group (p=0.001). The number of collected lymph nodes were significantly higher in the ePLND group than in the sPLND group (p=0.015).
Comparison of detection rates of positive lymph nodes according to the PLND method showed that the ePLND group had a higher percentage of patients with lymph node invasion than the sPLND group (35.8% vs. 28.9%, respectively) ( Table   2 ). However, the percentages of positive lymph nodes per total number of removed lymph nodes were the same between the 2 groups (both 8.2%). Subsequently, we evaluated the rate of lymph node invasion according to the region of the lymph nodes in patients who underwent ePLND ( Fig. 1) . A low but nonnegligible percentage of patients had lymph node invasions in the ePLND regions (common iliac, presacral, and para-aortic) There were no significant differences in early complication rates between the 2 groups (p=0.063) ( Table 3) Values are presented as number (%). SPLND: standard pelvic lymph node dissection, EPLND: extended pelvic lymph node dissection. Values are presented as number (%).
(Clavien-Dindo classification grade III or higher) was lower in the ePLND group, but the group had a higher number of low-grade complications (Clavien-Dindo classification grade II or lower). Detailed information on overall complications is summarized in Table 4 . The most prevalent complications in the sPLND group were perioperative transfusion, wound dehiscence, and ileus. In the ePLND group, the most prevalent complications were urinary tract infection, wound dehiscence, ileus, and anastomosis site leakage. Furthermore, there were no significant differences in rate of postoperative complication according to the type of urinary diversion in our cohort (p=0.486) ( Table 5) .
DISCUSSION
In the present study, we compared the diagnostic accuracy of ePLND and sPLND in patients with bladder cancer who underwent radical cystectomy with PLND as well as the postoperative complications. The rates of patients who had positive lymph nodes were higher in the ePLND group, but the group showed more favorable clinical and pathologic stages than the sPLND group. We believe that these findings imply the higher nodal staging ability of ePLND compared with sPLND.
The absence of consensus in the optimal extent of PLND is because of the lack of randomized controlled studies on this subject. However, there has been a continuous accumulation of evidence, albeit of low level, showing that ePLND has a more accurate staging ability and superior prognostic effect. 5, 6 Herr et al. 5 analyzed 268 MIBC patients treated with radical cystectomy and reported a positive association between high number of removed lymph nodes and better prognosis. Konety et al. 6 also analyzed a large cohort of 1,923 patients from the database of the Surveillance, Epidemiology and End Results program and concluded that the extent of PLND was significantly related with better prognosis in terms of cancer-specific survival (CSS). 6 The patients in their study who had zero to 3 resected lymph nodes showed significantly worse CSS than those with 3 or more. Holmer et al. 16 patients. The operation duration was significantly longer in the ePLND group than in the sPLND group (p＜0.01). As the low-grade complications were similar in both PLND groups, complications requiring interventions were more prevalent in the ePLND group, but the difference was not significant (p=0.28). They concluded that ePLND did not increase the morbidity of radical cystectomy. Poulsen et al. 20 also reported that no significant impact from the extent of PLND on mortality or lymphocele formation. Another multicenter study, by
Leissner et al., 17 also pointed that there were no significant adverse side effects related with ePLND. In the present study, we observed that the complication rates were quite comparable between the ePLND and sPLND groups with no significant differences (p=0.063).
Our study has some limitations. First, although anatomic-pathologic data on lymph node invasion were prospectively collected, medical records were retrospectively reviewed.
Therefore, our study may have some inherent bias from its retrospective data analyses. Second, the study included only the Korean population; therefore, care must be taken when applying our results to other racial groups. Most importantly, we could not analyze the survival outcomes based on the extent of PLND. A further study with prospective randomized design is needed to determine the optimal extent of PLND in patients treated with radical cystectomy.
CONCLUSIONS
The ePLND showed more accurate nodal staging ability than sPLND in patients who underwent radical cystectomy for localized bladder cancer. Moreover, there were no significant differences in complication rates between the 2 groups.
